Phase 3 Study of First-Line Pembrolizumab +/- Vibostolimab (anti-TIGIT) in Patients With PD-L1-Positive Metastatic NSCLC

Hellmann M. D., Cho B. C., Juergens R., Cheng Y., De Castro G., Erman M., ...More

JOURNAL OF THORACIC ONCOLOGY, vol.16, no.10, 2021 (SCI-Expanded, Scopus)

  • Publication Type: Article / Abstract
  • Volume: 16 Issue: 10
  • Publication Date: 2021
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Keywords: metastatic non-small-cell lung cancer, Pembrolizumab, vibostolimab
  • Hacettepe University Affiliated: Yes